These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 228870)

  • 1. Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide.
    Glaser M
    Cell Immunol; 1979 Dec; 48(2):339-45. PubMed ID: 228870
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.
    Glaser M
    J Natl Cancer Inst; 1978 Nov; 61(5):1351-5. PubMed ID: 213615
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.
    Glaser M
    J Exp Med; 1979 Mar; 149(3):774-9. PubMed ID: 219129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of specific tumor immunity against a syngeneic SV40-induced sarcoma in mice by retinoic acid.
    Glaser M; Lotan R
    Cell Immunol; 1979 Jun; 45(1):175-81. PubMed ID: 222484
    [No Abstract]   [Full Text] [Related]  

  • 5. Collaboration between distinct subpopulations of T cells in in vitro generation of effector cells capable of growth prevention of syngeneic SV40-induced sarcoma in mice.
    Glaser M
    Cell Immunol; 1979 Nov; 48(1):71-8. PubMed ID: 228868
    [No Abstract]   [Full Text] [Related]  

  • 6. Augmentation of specifici immune response against syngeneic SV40-induced tumor-associated antigens by splenectomy.
    Glaser M
    Cell Immunol; 1979 Jun; 45(1):230-6. PubMed ID: 222486
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of simian virus 40 (SV40) transplantation immunity in mice by SV40-transformed cells of various species.
    Law LW; Takemoto KK; Rogers MJ; Ting RC
    J Natl Cancer Inst; 1977 Nov; 59(5):1523-6. PubMed ID: 198568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic properties of a soluble tumor rejection antigen (TSTA) from a Simian virus 40-induced sarcoma.
    Rogers MJ; Law LW
    Int J Cancer; 1979 Jan; 23(1):89-96. PubMed ID: 83307
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM
    Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of the rhythm of cyclophosphamide administration on its antitumor action and on the immune response of mice with methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM; Botsmanov KV
    Biull Eksp Biol Med; 1974 Jul; 78(7):87-90. PubMed ID: 4451721
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-T cell collaboration in rejection of a syngeneic SV40-induced sarcoma in mice.
    Glasser M; Law LW
    Nature; 1978 Jun; 273(5661):385-7. PubMed ID: 207992
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens.
    Trinchieri G; Aden DP; Knowles BB
    Nature; 1976 May; 261(5558):312-4. PubMed ID: 179019
    [No Abstract]   [Full Text] [Related]  

  • 14. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F; Levy JP
    Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
    [No Abstract]   [Full Text] [Related]  

  • 15. A requirement for three cell types for in vitro generation of specific secondary cell-mediated cytotoxic response against SV40-induced tumor-associated antigens in mice.
    Glaser M
    Cell Immunol; 1980 Feb; 49(2):415-20. PubMed ID: 6243517
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE; Cerottini JC; Brunner KT
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed hypersensitivity to simian virus 40 tumor cells in BALB-c mice demonstrated by a radioisotopic foot-pad assay.
    Paranjpe MS; Boone CW
    J Natl Cancer Inst; 1972 Feb; 48(2):563-6. PubMed ID: 4347042
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative in vivo studies of soluble simian virus 40 tumor-specific transplantation antigens of the mouse.
    Henriksen O; Law LW; Appella E
    J Natl Cancer Inst; 1977 Jun; 58(6):1785-8. PubMed ID: 194045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in cell-mediated immunity during growth of a syngeneic simian virus-induced tumor.
    Howell SB; Dean JH; Law LW
    Int J Cancer; 1975 Jan; 15(1):152-69. PubMed ID: 236258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of tumor specific delayed type hypersensitivity reaction and tumor protection to SV40-induced mKSA fibrosarcoma.
    Kadhim S; Barrington-Leigh J
    Cancer Immunol Immunother; 1986; 21(1):39-44. PubMed ID: 3002606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.